Prognostic and Predictive Importance of Body Mass Index and Type 2 Diabetes in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 Phase III Trial of Pembrolizumab Versus Placebo in Resected High-Risk Stage III Melanoma
EJC Skin Cancer(2025)
Key words
melanoma,immunotherapy,body mass index,type two diabetes,immune-related adverse events
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined